Find News

Filter articles

Applied Filters

Showing 31 to 40 of 133 results

Astellas-backed Crescendo pairs up with Zai Lab in licensing deal

China, UK31-05-2018

UK-based Crescendo Biologics has agreed a global licensing deal with biopharma company Zai Lab which will see Zai Lab develop and commercialise an antibody, “VH domain therapeutic”, for applications in inflammatory diseases. 

Apotex and Strides to merge Australia generics business


Canadian generics maker Apotex and India-based Strides Shasun will merge their Australian operations in a bid to create the leading player in the Australian generics pharmaceutical market.

AstraZeneca sells Seroquel rights for $538m

China, UK10-05-2018

AstraZeneca has agreed to sell its rights to Seroquel (quetiapine fumarate) and Seroquel XR to China-based pharmaceutical company Luye Pharma Group for $538 million.

Celgene drops trademark claim against online pharmacies

India, US10-05-2018

Biopharmaceutical company Celgene has ditched its trademark quarrel with the owners of India-based online pharmacies importing generics into the US.

Merck KGaA secures CRISPR patent in China


China’s State Intellectual Property Office has granted Merck KGaA a patent covering its CRISPR technology used in a genomic-integration method for eukaryotic cells.

Takeda makes fourth offer to buy Shire

Ireland, Japan23-04-2018

Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

China releases measures to boost pharma IP protection


China’s government has announced a series of measures to increase the country’s importation of drugs, including enhanced IP protection in the pharmaceutical industry.

China to slash tax for generic makers to 15%


China’s government has announced plans to implement preferential tax rates to generic drug makers in a bid to encourage the manufacturing of generics. 

Fujifilm makes $800m acquisition


Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.  

Eisai unites with Nichi-Iko to boost generics business


Eisai has partnered with fellow Japanese pharmaceutical company Nichi-Iko Pharmaceutical to expand and grow Nichi-Iko’s generic business.

Showing 31 to 40 of 133 results